Genomics Assessment Platform
How this assessment platform benefits ONDRI’s research
ONDRI’s research investigates how a person’s genetic makeup and genetic patterns may explain why some people are more likely to get neurodegenerative diseases than others.
Video: The genomics assessment
To access closed captioning, or read the words, click on CC at bottom of the video
ONDRI protocol
Participants visit a medical laboratory where a blood sample is taken.
DNA is isolated from the blood samples by ONDRI expert researchers. This DNA is then analyzed to identify changes that may contribute to neurodegenerative disease development or presentation.
This assessment was used in the following studies:
For details on data collected through the genomics assessment platform, click here.
Related resources:
ONDRISeq: a custom gene panel for neurodegeneration
Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Genetic variation in the ONDRI study cohort
PD, NOTCH3 Genetic Variants, & White Matter Hyperintensities
Learn about ONDRI’s other assessment platforms
Clinical
Neuroimaging
Eye Tracking
Neuroinformatics & Biostatistics
Gait (Walking) & Balance
Neuropsychology
Genomics
Remote Monitoring
Molecular/ Neuropathology
